Preliminary Results of a Phase I Study of Pharmacological Ascorbate (P-AscH-) with Gemcitabine Chemoradiotherapy in Pancreatic Cancer

被引：1
|
作者：
Wilkes, Justin [1 ]
Allen, Bryan [1 ]
Berg, Daniel J. [1 ]
Wagner, Brett [1 ]
Du, Juan [1 ]
Bodeker, Kellie [1 ]
Ahmann, Logan [1 ]
Vollstedt, Sandy [1 ]
Brown, Heather [1 ]
Alexander, Matthew [1 ]
Cullen, Joseph [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2016年 / 100卷
关键词：
D O I：
10.1016/j.freeradbiomed.2016.10.347
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
306
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [31] PHASE I/II STUDY OF NC-6004, A NOVEL MICELLAR FORMULATION OF CISPLATIN, IN COMBINATION WITH GEMCITABINE IN PATIENTS WITH PANCREATIC CANCER IN ASIA - RESULTS OF PHASE I
    Su, W.
    Chen, L.
    Li, C.
    Chen, J.
    Lin, Y.
    Choo, S.
    Matsumura, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 247 - 247
  • [32] Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: Preliminary results
    Steward, WP
    Dunlop, DJ
    Dabouis, G
    Lacroix, H
    Talbot, D
    SEMINARS IN ONCOLOGY, 1996, 23 (05) : 43 - 47
  • [33] Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancer
    Furuse, J
    Ishii, H
    Okusaka, T
    Nagase, M
    Nakachi, K
    Ueno, H
    Ikeda, M
    Morizane, C
    Yoshino, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (12) : 733 - 738
  • [34] Phase I study of nab-paclitaxel and gemcitabine combination in patients with advanced pancreatic cancer
    Drengler, R. L.
    Smith, L. S.
    Wood, T. E.
    Borad, M. J.
    Ramanathan, R. K.
    Laheru, D. A.
    Hidalgo, M.
    Von Hoff, D. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer
    Samaras, Panagiotis
    Tusup, Marina
    Thi Dan Linh Nguyen-Kim
    Seifert, Burkhardt
    Bachmann, Helga
    von Moos, Roger
    Knuth, Alexander
    Pascolo, Steve
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (05) : 1005 - 1012
  • [36] Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer
    Hidalgo, M
    Castellano, D
    Paz-Ares, L
    Gravalos, C
    Diaz-Puente, M
    Hitt, R
    Alonso, S
    Cortes-Funes, H
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 585 - 592
  • [37] Erlotinib, gemcitabine, paclitaxel and radiation for locally advanced pancreatic cancer: A phase I study.
    Iannitti, D
    Dipetrillo, T
    Cruff, D
    Sambandam, S
    Maia, C
    Hughes, M
    Oldenburg, N
    Thornton, K
    Kennedy, T
    Safran, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 336S - 336S
  • [38] Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
    Yaman Suleiman
    Amit Mahipal
    David Shibata
    Erin M. Siegel
    Helen Jump
    William J. Fulp
    Gregory M. Springett
    Richard Kim
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 481 - 487
  • [39] Hypofractionated Tomotherapy with Concomitant Chemotherapy in Pancreatic Adenocarcinoma: Preliminary Results of a Phase I Study
    Slim, N.
    Cereda, S.
    Passoni, P.
    Reni, M.
    Cattaneo, M.
    Alongi, F.
    Sangalli, G.
    Bettinardi, V.
    Mancosu, P.
    Di Muzio, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S284 - S284
  • [40] Phase II study of gemcitabine in combination with docetaxel in patients with advanced pancreatic carcinoma. Preliminary results.
    Chauvenet, L
    Des Guetz, G
    Aparicio, T
    Boiron, C
    Ecochard, L
    Chirat, E
    Mayeur, D
    Vanica, R
    Bouleuc, C
    Paraiso, D
    Pujade-Lauraine, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 359S - 359S
12345